skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Multidrug chemotherapy (vincristine-bleomycin-methotrexate) followed by radiotherapy in inoperable carcinomas of the head and neck: preliminary report of a pilot study of the Radiation Therapy Oncology Group

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

This is a preliminary report on the Radiation Therapy Oncology Group (RTOG) pilot study 77-08, of a combination of chemotherapy with vincristine-bleomycin-methotrexate, followed by radiotherapy, for inoperable carcinomas of the head and neck. The main objectives of the study were to determine toxicity and tumor control. Patients who were included had untreated carcinomas, with no distant metastases, and with adequate pulmonary, renal, and liver function. Forty patients were registered for the study. Chemotherapy started with vincristine--1.5 mgs/m/sup 2/ (maximum of 2 mgs) by I.V. injection, followed by bleomycin drip for 48 hours (15 units/day), and then methotrexate (200 mgs/m/sup 2/ divided in equal doses 6 hours apart) with folinic acid rescue. Eleven patients received one course of the stated chemotherapy; 28 were given two courses with one week rest period between them. Radical curative radiotherapy was started usually two weeks after chemotherapy. A surgical procedure was considered if the patient was found operable after receiving a dose of 5000 rad with continuous therapy or at 3000 rad with split-course therapy. The level of toxicity that resulted from this combined therapy was considered acceptable. The percentage of complete response of the primary tumor was 6% with chemotherapy; this increased to 46% after irradiation, and to 65% when surgery was added.

Research Organization:
Univ. of Puerto Rico School of Medicine, San Juan
OSTI ID:
7029358
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 6:6
Country of Publication:
United States
Language:
English

Similar Records

Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck cancer
Journal Article · Sat May 01 00:00:00 EDT 1982 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:7029358

Combined methotrexate and high-dose vincristine chemotherapy with radiation therapy for small cell bronchogenic carcinoma
Journal Article · Mon Apr 01 00:00:00 EST 1985 · Cancer (Philadelphia); (United States) · OSTI ID:7029358

Comparison of survival in patients with non-oat cell carcinoma of lung using various types of treatment modalities
Journal Article · Wed Sep 01 00:00:00 EDT 1982 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:7029358